High rates of drug resistance among HIV-positive infants in South Africa
ART soon after birth for HIV-infected babies can achieve sustained viral suppression and reduce pool of HIV-infected cells
Second analysis concludes that we can't eliminate the long-term possibility of HIV transmission from someone on treatment
HIV incidence is high among pregnant and postpartum women and increases the risk of mother-to-child transmission
Efavirenz-based ART matches lopinavir/ritonavir for perinatal HIV treatment
Sexually transmitted infections greatly increase the risk of HIV infection in pregnancy
Lopinavir/ritonavir or 3TC PrEP equally protective against infant HIV infection during breastfeeding
Maternal deaths due to HIV not declining despite PMTCT successes in South Africa
